|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 90.3 TWD | -0.55% |
|
+4.39% | +12.17% |
| May. 08 | CH Biotech R&D Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 07 | CH Biotech R&D Co., Ltd.(TWSE:6534) added to Taiwan TAIEX Index | CI |
CH Biotech R&D Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 800.85 million compared to TWD 591.04 million a year ago. Net income was TWD 392.85 million compared to TWD 269.34 million a year ago.
Basic earnings per share from continuing operations was TWD 4.05 compared to TWD 2.77 a year ago. Diluted earnings per share from continuing operations was TWD 3.96 compared to TWD 2.74 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +12.17% | 288M | |
| +17.80% | 39.34B | |
| -.--% | 11.28B | |
| +1.48% | 7.99B | |
| +1.79% | 6.51B | |
| -2.15% | 6.18B | |
| +36.99% | 5.43B | |
| -13.59% | 5.37B | |
| -13.00% | 4.61B | |
| +4.12% | 3.89B |
CH BIOTECH R&D CO., LTD. 
